Key facts
- Cordata’s last known valuation is $28.0M.
- It has raised $13.2M; the latest was Later Stage VC ($3.0M) in Sep 2024.
- Notable investors include First Trust Capital Partners, JobsOhio Ventures, CincyTech, Ohio Department of Development, 121G — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Cordata
- ·The full record, as it builds
Funding rounds
No funding rounds for Cordata are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cordata
Developer of a care coordination platform designed to facilitate collaboration and teamwork among healthcare organizations to effectively treat people suffering from complex diseases. The company's tool offers data-driven insights, mobile screening programs, and direct patient engagement to generate clinical and business outcomes, enabling patients to connect to hospitals and healthcare organizations for cost-effective treatments.
- Sector
- Healthcare
- HQ
- Cincinnati, OH, United States
- Founded
- 2002
- Employees
- 41
- Website
- cordatahealth.com/
- Ownership
- Privately Held (backing)
Cordata doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cordata shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cordata in its N-PORT filings yet. We sweep new filings monthly.